Johnson & Johnson

Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation—bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better.

Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Our Family of Companies comprises:

  • The world’s sixth-largest consumer health company
  • The world’s largest and most diverse medical devices company
  • The world’s sixth-largest biologics company
  • And the world’s fifth-largest pharmaceuticals company

We have more than 265 operating companies in more than 60 countries.

Company Growth (employees)
New Brunswick, US
Size (employees)
126,400 (est)
Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, US

Key People at Johnson & Johnson

Alex Gorsky

Alex Gorsky

Dominic J. Caruso

Dominic J. Caruso

Ronald A. Williams

Ronald A. Williams

Independent Director
Michael Sneed

Michael Sneed

VP, Global Corporate Affairs
Peter Fasolo

Peter Fasolo

Executive VP, CHRO
Paul Stoffels

Paul Stoffels

Executive VP & CSO

Johnson & Johnson Office Locations

Johnson & Johnson has an office in New Brunswick
New Brunswick, US (HQ)
One Johnson & Johnson Plaza

Johnson & Johnson Data and Metrics

Johnson & Johnson Financial Metrics

Johnson & Johnson's revenue was reported to be $71.9 b in FY, 2016 which is a 3% increase from the previous period.

Revenue (FY, 2016)

71.9 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

50.2 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

16.5 b

EBIT (FY, 2016)

16.5 b

Market capitalization (25-Jul-2017)

363.3 b

Cash (31-Dec-2016)

19 b


366.7 b
Johnson & Johnson's current market capitalization is $363.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


71.3 b74.3 b70.1 b71.9 b

Revenue growth, %


Cost of goods sold

22.3 b22.7 b21.5 b21.7 b

Gross profit

49 b51.6 b48.5 b50.2 b

Gross profit Margin, %


Sales and marketing expense

21.8 b22 b21.2 b19.9 b

R&D expense

8.2 b8.5 b9 b9.1 b

Operating expense total

30 b30.4 b30.2 b29 b

Depreciation and amortization

4.1 b3.9 b3.7 b3.8 b


16.4 b21.6 b19.2 b16.5 b

EBIT margin, %


Interest expense

580 m533 m552 m726 m

Interest income

74 m67 m128 m368 m

Pre tax profit

15.5 b20.6 b19.2 b19.8 b

Income tax expense

1.6 b4.2 b3.8 b3.3 b

Net Income

13.8 b16.3 b15.4 b16.5 b
USDY, 2010Y, 2011Y, 2012FY, 2013FY, 2014FY, 2015FY, 2016


15.8 b19.4 b24.5 b20.9 b14.5 b13.7 b19 b


7.9 b8.2 b8.1 b8.1 b

Current Assets

56.4 b59.3 b60.2 b65 b


16.7 b16.1 b15.9 b15.9 b


22.8 b21.8 b21.6 b22.8 b

Total Assets

132.7 b131.1 b133.4 b141.2 b

Accounts Payable

6.3 b7.6 b6.7 b6.9 b

Total Debt

13.3 b15.1 b12.9 b22.4 b

Current Liabilities

25.7 b25.1 b27.7 b26.3 b

Retained Earnings

89.5 b97.2 b103.9 b110.6 b

Total Equity

71.2 b70.4 b

Debt to Equity Ratio

0.2 x0.3 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x0.2 x

Financial Leverage

1.9 x2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

13.8 b16.3 b15.4 b16.5 b

Accounts Receivable

(632 m)(247 m)(433 m)(1.1 b)


(622 m)(1.1 b)(449 m)(249 m)

Accounts Payable

1.8 b955 m656 m

Cash From Operating Activities

17.4 b18.5 b19.3 b18.8 b

Purchases of PP&E

(3.6 b)(3.7 b)(3.5 b)(3.2 b)

Cash From Investing Activities

(5.1 b)(12.3 b)(7.7 b)(4.8 b)

Cash From Financing Activities

(6.1 b)(12.3 b)(10.8 b)(8.6 b)

Interest Paid

596 m603 m515 m730 m

Income Taxes Paid

3.2 b3.5 b2.9 b2.8 b
USDY, 2016


22.2 x


19.5 x


566.7 k


0.3 x


0.2 x

Financial Leverage

2 x

Johnson & Johnson Operating Metrics

Johnson & Johnson's Facilities was reported to be 119 in FY, 2016, which is a 2% decrease from the previous period
FY, 2014FY, 2015FY, 2016

Discovery Projects




Drugs Approved by FDA


    Johnson & Johnson Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Actelion PharmaceuticalsJanuary 26, 2017$30 b
    Abott Medical OpticsSeptember 16, 2016$4.3 b
    Vogue InternationalJune 02, 2016$3.3 b
    Novira TherapeuticsNovember 08, 2015
    XO1March 20, 2015
    Alios BioPharmaSeptember 30, 2014$1.8 b
    Aragon PharmaceuticalsJune 17, 2013$1 b

    Johnson & Johnson Market Value History

    Johnson & Johnson Revenue Breakdown

    Johnson & Johnson Median Salaries

    Source: 32 public H-1B filings from Johnson & Johnson

    Johnson & Johnson Online and Social Media Presence

    Johnson & Johnson Company Life and Culture

    You may also be interested in